Concepedia

Author

Emmanuel J. Sablan

Amplyx Pharmaceuticals (United States)

Also Known As

Emmanuel J. Sablan

2

Publications

123

Citations

2

H-Index

19

Concepts

All Affiliations

Amplyx Pharmaceuticals (United States)
EJ

About

Emmanuel J. Sablan is an author at Amplyx Pharmaceuticals (United States) specializing in health sciences, diabetes, and gastrointestinal pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

2

2

123

2

Medicine

2

2

123

3

Diabetes

2

2

123

4

Endocrinology

2

2

123

5

Biochemistry

1

1

32

Emmanuel J. Sablan

×

2

Publications

123

Citations

2

H-Index

YearCitations

Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents

Krystyna Tatarkiewicz, Pam Smith, Emmanuel J. Sablan,

American Journal of Physiology-Endocrinology and Metabolism

2010

91

Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor

Krystyna Tatarkiewicz, Emmanuel J. Sablan, Clara J. Polizzi,

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology

2014

32

Page 1